elacridar has been researched along with Leukemia P388 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du Vignaud, P; Grand-Perret, T; Hyafil, F; Vergely, C | 1 |
1 other study(ies) available for elacridar and Leukemia P388
Article | Year |
---|---|
In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.
Topics: Acridines; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Colonic Neoplasms; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Female; Humans; Isoquinolines; Leukemia P388; Mice; Mice, Inbred DBA; Ovary; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1993 |